The aims of this study were to investigate possible associations of ficolins and/or MBL levels in sera taken before starting chemotherapy with acute myeloid leukaemia itself and with susceptibility to hospital infections after chemotherapy. This evidence concerns the gene MBL2 and acute myeloid leukemia.